2 Hematology Flashcards

1
Q

What are the initial steps of primary hemostasis?

A

Subendothelial collagen exposure –> Platelet adhesion–> shape change –> granulation release (ADP, TXA2) –> Recruitment –> hemostatic plug (Aggregation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three initial responses to vascular injury?

A

Vascular vasoconstriction
Platelet adhesion
Thrombin generation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What initiates the intrinsic pathway?

A

Exposed collagen
Prekallikrein
HMW kininogen
Factor XII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the steps in the intrinsic pathway?

A

Exposed collagen/prekallikrein/HMW kininogen/factor XII

  • -> activates XI
  • -> activate IX, then add VIII
  • -> activate X, then add V
  • -> convert prothrombin (Factor II) to thrombin
  • -> thrombin then converts fibrinogen to fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What initiates the extrinsic pathway?

A

Cellular injury –> release of tissue factor

Factor VII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the steps in the extrinsic pathway?

A

Cellular injury leads to release of tissue factor - reacts with VII

  • -> Activates X, then add V
  • -> convert prothrombin to thrombin
  • -> thrombin then converts fibrinogen to fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the steps in the common pathway?

A

Prothrombin (Factor II) is converted to thrombin

–> Thrombin then converts fibrinogen to fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the prothrombin complex?

A

X, V, Ca, platelet factor 3 and prothrombin
Forms on platelets
Catalyzes the formation of thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the convergence point for both coagulation pathways?

A

Factor X

Needed for conversion of prothrombin to thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Function of Tissue factor pathway inhibitor?

A

Inhibits factor X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Function of Fibrin

A

Links platelets together
Binds GpIIb/IIIa molecule
Forms a platelet plug - hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Role of XIII

A

Helps crosslink fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Functions of thrombin

A

Key to coagulation
Converts fibrinogen to fibrin and fibrin split products
Activates factors V and VIII
Activates platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Function of Antithrombin III

A

Key to anticoagulation
Binds and inhibits thrombin
Inhibits factors IX, X and XI
Heparin activates AT-III (up to 1000x normal activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Function of Protein C

A

Vitamin K-dependent
Degrades factors V and VIII
Degrades fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Function of Protein S

A

Vitamin K-dependent

Protein C cofactor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What enzymes regulate fibrinolysis?

A

Tissue plasminoagen activator
Plasmin
Alpha-2 antiplasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Function of Tissue plasminogen activator

A

Released from endothelium

Converts plasminogen to plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Function of Plasmin

A

Degrades factors V and VIII, fibrinogen and fibrin

Causes degradation of platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Function of Alpha-2 antiplasmin

A

Natural inhibitor of plasmin

Releases from endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which factor has the shortest half-life?

A

Factor VII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which factors are liable - activity is lost in stored blood, but not lost in FFP?

A

Factors V and VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which factors is NOT synthesized in the liver? Where is is synthesized?

A

Factor VIII

Synthesized in endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which factors are vitamin K-dependent?

A

II, VII, IX, X

Proteins C & S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How long does it take for Vitamin K to be effective?
6 hours
26
How long does it take for FFP to be effective? How long does it last?
Immediate | Lasts 6 hours
27
Which factor is prothrombin?
Factor II
28
What is the normal half life of RBCs?
120 days
29
What is the normal half life of platelets?
7 days
30
What is the normal half life of PMNs?
1-2 days
31
Function and source of Prostacyclin (PGI2)
From endothelium Decreases platelet aggregation, promotes vasodilation Antagonistic to TXA2
32
Function and source of Thromboxane (TXA2)
From platelets Increases platelet aggregation and vasoconstriction Triggers release of calcium in platelets - exposes GpIIb/IIIa receptors and causes platelet-to-platelet binding Platelet-to-collagen binding also occurs (GpIb receptors)
33
Contents of cryoprecipitate
Highest concentration of vWF-VIII Used in von Willibrand's disease, Hemophillia A (Factor VIII deficiency) Has high levels of fibrinogen
34
Contents of fresh frozen plasma
High levels of all coagulation factors, protein C, protein S, and AT-III
35
Function of DDAVP and conjugated estrogens
Causes release of VIII and vWF from endothelium
36
What does PT assess?
Measures II, V, VII, X, fibrinogen | Best for liver synthetic function
37
What does PTT assess?
Measures all factors, except VII and XIII, fibrinogen | Goal PTT 60-90sec
38
Goal Activated Clotting Time?
Routine anticoagulation ACT 150-200sec | For pardiopulmonary bypass >460sec
39
INR level that is a relative CI for surgical proceedures
INR > 1.5
40
INR level that is a relative CI for central line placement, percutaneous needle biopsies or eye surgery
INR > 1.3
41
What is the most common cause of surgical bleeding?
Incomplete hemostasis
42
What is the most common congenital bleeding disorder?
Von Willebrand's disease
43
Inheritance patterns for vW disease
Type I/II - AD | Type III - AR
44
Function of vWF
GpIb receptor on platelets to collagen
45
Coagulation test results in vWF disease
PT normal PTT can be normal or abnormal Prolonged bleeding time (ristocetin test)
46
Which form of vWF disease is the most common? Symptoms?
Type I | Mild symptoms
47
Which form of vWF disease has the most severe bleeding?
Type III
48
What is the defect in Type I vWF disease? Treatment?
Reduced quantity of vWF | Tx: recombinant VIII:vWF, DDAVP (increased release of vWF), cryoprecipitate
49
What is the defect in Type II vWF disease? Treatment?
Defect in vWF molecule itself, doesn't work well | Tx: Recombinant VIII:vWF, cryoprecipitate
50
What is the defect in Type III vWF disease? Treatment?
Complete deficiency of vWF | Ts: Recombinant VIII:vWF, cryoprecipitate
51
Why do you not give DDAVP in type II/III vWF disease?
Because they have crappy vWF (type II) or no vWF (type III), trying to increase the release of vWF will have no effect
52
Hemophilia A
VIII deficiency Sex-linked recessive Prolonged PTT, normal PT Sx: joint bleeding, epistaxis, ICH, hematuria
53
What are goals of VIII in Hemophilia A for surgery?
Need levels 100% pre-op | Keep >80% post-op for 10-14 days
54
How do you treat Hemophilia A with joint bleeding?
Do NOT aspirate Ice, keep joint mobile with ROM exercises Give factor VIII concentrate or cryoprecipitate
55
How do you treat Hemophilia A with epistaxis, ICH or hematuria?
Recombinant factor VIII or cryoprecipitate
56
Why do Hemophilia A patients not bleed at circumcision?
Factor VIII crosses the placenta
57
Hemophilia B
IX deficiency (Christmas disease) Sex-linked recessive Prolonged PTT, normal PT Tx: Recombinant factor IX or FFP
58
Factor VII deficiency
Prolonged PT and normal PTT Bleeding tendency Tx: recombinant factor VII concentrate or FFP
59
Symptoms of platelet disorders
Bruising, epistaxis, mucosal bleeding, petechiae, purpura
60
Causes of acquired thrombocytopenia
H2 blockers | Heparin
61
Glanzmann's thrombocytopenia
GpIIb/IIIa receptor deficiency on platelets - they cannot bind to each other Fibrin normally links the receptors Tx: Platelets
62
Bernard Soulier thrombocytopenia
GpIb receptor deficiency on platelets - they cannot bind to collagen vWF normally links GpIb to collagen Tx: Platelets
63
Uremia platelet dysfunction
Inhibits platelet function | Tx: hemodialysis, DDAVP, platelets
64
Heparin-induced thrombocytopenia - Type I
``` Self limited Onset 2-3 days Platelets ~100,000 Occurs in 10-20% patients No antibodies Tx: Monitor patient - do not need to stop Heparin ```
65
Heparin-induced thrombocytopenia - Type II
``` Severe Onset 5-10 days Platelets 10-20,000 Antiplatelet antibodies (IgG PF4) Can also cause platelet aggregation/thrombosis White clot Test: Platelet factor 4(PFE4) antibody; seretonin assay Tx: Stop heparin, start argatroban ```
66
What is argatroban?
Direct thrombin inhibitor
67
Disseminated intravascular coagulation (DIC)
Decreased platelets, low fibrinogen, high fibrin split products, high D-dimer Prolonged PT/PTT Initiated by tissue factor Tx: treat underlying cause (i.e. sepsis)
68
Anticoagulation effect of ASA
Inhibits cyclooxygenase in platelets and decreases TXA2 Platelets lack DNA - cannot re-synthesize COX, need to wait for new platelets to form Stop 7 days before surgery - prolonged bleeding time Reversal - platelets
69
Anticoagulation effect of Clopidogrel (Plavix)
ADP receptor antagonist Stop 7 days before surgery Reversal - platelets
70
Anticoagulation effect of Coumadin
Inhibits Vitamin K decarboxylation of clotting factors | Stop 7 days before surgery - bridge with Heparin
71
Operative platelet goals for surgery?
Pre-op >50,000 | Post-op >20,000
72
Thrombolytic problems in prostate surgery?
Cane release urokinase, activates plasminogen, which causes thrombolysis Tx: g-aminocaproic acid (Amicar)
73
How do hypercoagulability disorders present?
Venous or arterial thrombosis Emobli DVT, PE, stroke
74
Factor V Leiden mutation
Most common congenital hypercoagulability disorder Factor V is resistance to activated protein C Tx: heparin, warfarin
75
Hyperhomocysteinemia
Hypercoagulability Tx: Folic acid B12 (This is why they assess it in stroke patients)
76
Prothrombin gene defect G20210 A
Hypercoagulabiltiy | Tx: Heparin, warfarin
77
Protein C or S deficiency
Hypercoagulability | Tx: Heparin, warfarin
78
Antithrombin III deficiency
Hypercoagulability Can develop after previous heparin exposure (development of antibodies) NOTE: Heparin will no longer work for them Tx: recombinant AT-III concentrate or FFP, followed by Heparin, then warfarin
79
Dysfibinogenemia, dysplasminogenemia
Hypercoagulability | Tx: heparin, warfarin
80
Polycythemia vera
Defect in platelet function and extra RBCs, causes thrombosis Keep Hct <48, platelets <400 before surgery Tx: Phlebotomy, ASA
81
Anti-phospholipid antibody syndrome
Not always associated with SLE Procoagulant Prolonged PTT but hypercoagulable Caused by antibodies to cardiolipin and lupus anticoagulant (phospholipids) Dx: prolonged PTT (not corrected with FFP), positive Russell viper venom time, false-positive RPR test for syphillis Tx: Heparin, warfarin
82
Causes of acquired hypercoagulability
``` Tobacco* Malignancy Inflammatory states Inflammatory bowel disease Infections Oral contraceptives Pregnancy Rheumatoid arthritis Post-op status Myeloproliferative disorders ```
83
Cardiopulmonary bypass effect on hypercoagulability
Activates factor XII (Hageman factor) | Tx: Heparin to prevent
84
Warfarin-induced skin necrosis
Occurs when starting coumadin without bridging with heparin Due to short half-life of protein C/S; procoagulant factors outlive them Patients with relative protein C deficiency are especially susceptible Tx: Heparin if occurs
85
Key elements in the development of venous thromboses
Virchow's triad | Stasis, endothelial injury, hypercoagulability
86
Key elements in the development of arterial thromboses
Endothelial injury
87
Risk factors for DVT
Stasis, venous injury and hypercoagulability
88
Post-operative treatment of DVT
1st - Warfarin for 6 months 2nd - Warfarin for 1 year 3rd or significant PE - Warfarin for lifetime
89
Indications for IVC filters?
CI to anti-coagulation Documented PE while on anti-coagulation Free-floating IVC, ilio-femoral, or deep femoral DVT Recent pulmonary embolectomy
90
Treatment of pulmonary embolism
Shock, despite massive inotropes/pressors --> go to OR | Stable - Heparin (thrombolytics not shown to have an improvement in survival) or suction catherter-based intervention
91
Most common source of PE
Ilio-femoral region
92
g-Aminocaproic acid (Amicar)
Anti-fibrinolytic Inhibits plasmin Uses: DIC, persistent bleeding following cardiopulmonary bypass, thrombolytic overdose
93
Warfarin (Coumadin)
Prevents vitamin K-dependent decarboxylation of glutamic residues on vitamin K-dependent factors
94
Sequential compression devices
Improves venous return | Induces fibrinolysis - release of tPA (tissue plasminogen activator) from endothelium
95
Heparin
Binds and activates anti-thrombin III (1000x more activity) Reversed with protamine (binds heparin) Half-life 60-90min Cleared by reticuloendothelial system Safe in pregnancy (does not cross placenta)
96
Side effects of long-term use of Heparin
Osteoporosis, alopecia
97
Protamine
Reverses Heparin by binding to it Cross reacts with NPH insulin or previous protamine exposure 1% get protamine reaction
98
Symptoms of protamine reaction
Hypotension Bradycardia Decreased heart function
99
Low molecular weight heparin | enoxaparin, fondaparinux
Binds and activates antithrombin II, but increases neutralization of just Xa, Thrombin Not reversed with protamine Lower risk of HIT compared to unfractionated heparin
100
Argatroban
Reversible direct thrombin inhibitor Metabolized in lifer Half-life is 50 min Used in patients with HITT
101
Bivalirudin (angiomax)
Reversible direct thrombin inhibitor Metabolized by protinase enzymes in the blood Half-life of 25 minutes
102
Hirudin (Hirulog)
From leeches Irreversible direct thrombin inhibitor Most potent direct inhibitor of thrombin High risk for beleding complications
103
Ancrod
Malayan pit viper venom | Stimulates tPA release
104
Thrombolytic medications
Streptokinase (high antigenicity) Urokinase tPA
105
MOA thrombolytic medications
Activate plasminogen Need for follow fibrinogen levels (<100 associated with increased risk/severity of bleeding Tx for thrombolytic overdose: g-aminocaproic acid (Amicar)
106
Contraindications to thrombolytic use
``` Absolute: - Active internal bleeding - <3mo CVA/neurosurgery - intracranial pathology - recent GI bleed Major: - <10d surgery, organ biopsy, delivery - Left heart thrombus - Active peptic ulcer - Recent major trauma - Uncontrolled HTN - Recent eye surgery Minor: - Minor surgery - Rcent CPR - Afib with mitral valve disease - Bacterial endocarditis - Hemostatic defects (renal or liver disease) - Diabetic hemorrhagic retinopathy - Pregnancy ```